New cancer therapies are frequently evaluated in multiple disease indications. We evaluated whether the probability of achieving US Food and Drug Administration (FDA) approval for a new cancer therapy ...

In a previous paper [3], the authors presented large sample optimum accelerated test plans to estimate the survival probability at a design stress assuming a linear logistic model, i. e. a linear ...

We identified a cohort of anticancer drugs with a first registered efficacy trial from 2007 to 2011 on ClinicalTrials.gov. We downloaded all clinical trials for each included drug from the initiation ...